Skip to main content
CYRX
NASDAQ Life Sciences

Cryoport 10-Q Details Q3 Loss, Positive 9-Month Cash Flow and December Note Repayment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Transportation & Logistics Stocks · Industrial
Sentiment info
Neutral
Importance info
7
Price
$17.81
Mkt Cap
$812.918M
52W Low
$7.61
52W High
$18.88
52W Position info
134% above low
Off High info
5.7% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

CYRX has more than doubled off its 52-week low of $7.61 on elevated volume (2.2× avg).

Summary

Cryoport's Q3 10-Q shows a $10.9 million net loss on $50.2 million of revenue, positive $10.1 million nine-month operating cash flow, and $393.1 million of liquidity against $186.2 million of convertible notes due in December 2026 that management intends to repay from cash.


Key Events · Earnings and Guidance · CYRX

  • Q3 Revenue Up 14% to $50.2M

    Total revenue rose to $50.2 million from $44.2 million, with Life Sciences Services up 17.8% to $28.6 million and Life Sciences Products up 8.4% to $21.7 million.

  • Q3 Net Loss of $10.9M

    Net loss was $10.9 million, or $0.25 per share attributable to common stockholders after a $2.0 million paid-in-kind preferred dividend, versus a $6.9 million loss a year earlier.

  • Nine-Month Operating Cash Flow Turns Positive

    Operating activities generated $10.1 million for the nine months ended September 30, 2026, versus $9.5 million used in the prior-year period.

  • $186.2M Convertible Notes Due December 2026

    The 0.75% convertible senior notes mature in December 2026; management intends to repay the $186.2 million principal from the $393.1 million of cash, cash equivalents and short-term investments on hand.


Analysis · CYRX · Life Sciences

The headline numbers were already out today, but the full 10-Q fills in what the press release did not: a $10.9 million Q3 net loss and $12.9 million attributable to common holders ($0.25 per share), plus a swing to $10.1 million of operating cash inflow for the first nine months versus a $9.5 million outflow a year earlier. The balance sheet is the real story — $393.1 million of cash and short-term investments against $186.2 million of 0.75% convertible notes due in December 2026, which management says it will repay from existing liquidity. That removes refinancing risk and leaves roughly $207 million of liquidity, but it also consumes over half the cash pile. Gross margin slipped to 47.5% from 48.2% on a mix shift toward lower-margin aluminum dewars, so the 14% revenue growth is not flowing through at full rate.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CYRX was trading at $17.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $812.9M. The 52-week trading range was $7.61 to $18.88. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CYRX - Latest Insights

CYRX
Nov 05, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $16.05
Real-time Price: $19.05 info
Change: +$3.00 (+19%) info
Market Cap: $965.843M info
CYRX
Jun 12, 2026, 6:38 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $14.21
Real-time Price: $19.05 info
Change: +$4.84 (+34%) info
Market Cap: $965.843M info
CYRX
Jun 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.19
Real-time Price: $19.05 info
Change: +$3.86 (+25%) info
Market Cap: $965.843M info
CYRX
Jun 08, 2026, 9:11 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $15.48
Real-time Price: $19.05 info
Change: +$3.57 (+23%) info
Market Cap: $965.843M info
CYRX
Jun 03, 2026, 4:35 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $16.50
Real-time Price: $19.05 info
Change: +$2.55 (+15%) info
Market Cap: $965.843M info